MedPath
FDA Approval

Ketoconazole

March 1, 2024

HUMAN PRESCRIPTION DRUG LABEL

Ketoconazole(20 mg in 1 mL)

Manufacturing Establishments (1)

RPK Pharmaceuticals, Inc.

RPK Pharmaceuticals, Inc.

147096275

Products (1)

Ketoconazole

53002-1381

ANDA076419

ANDA (C73584)

TOPICAL

February 21, 2017

Code: R9400W927IClass: ACTIBQuantity: 20 mg in 1 mL
COCO DIETHANOLAMIDEInactive
Code: 92005F972DClass: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
DISODIUM LAURETH SULFOSUCCINATEInactive
Code: D6DH1DTN7EClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
IMIDUREAInactive
Code: M629807ATLClass: IACT
PEG-120 METHYL GLUCOSE DIOLEATEInactive
Code: YM0K64F20VClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM LAURETH-3 SULFATEInactive
Code: BPV390UAP0Class: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ketoconazole 2% Shampoo

Label Image


CLINICAL PHARMACOLOGY SECTION

CLINICAL PHARMACOLOGY

Tinea (pityriasis) versicolor is a non-contagious infection of the skin caused by Pityrosporum orbiculare (Malassezia furfur). This commensal organism is part of the normal skin flora. In susceptible individuals the condition is often recurrent and may give rise to hyperpigmented or hypopigmented patches on the trunk which may extend to the neck, arms and upper thighs. Treatment of the infection may not immediately result in restoration of pigment to the affected sites. Normalization of pigment following successful therapy is variable and may take months, depending on individual skin type and incidental skin exposure. The rate of recurrence of infection is variable.

Ketoconazole was not detected in plasma in 39 patients who shampooed 4-10 times per week for 6 months, or in 33 patients who shampooed 2-3 times per week for 3-26 months (mean: 16 months).

An exaggerated use washing test on the sensitive antecubital skin of 10 subjects twice daily for five consecutive days showed that the irritancy potential of ketoconazole shampoo, 2% was significantly less than that of 2.5% selenium sulfide shampoo.

A human sensitization test, a phototoxicity study, and a photoallergy study conducted in 38 male and 22 female volunteers showed no contact sensitization of the delayed hypersensitivity type, no phototoxicity and no photoallergenic potential due to ketoconazole shampoo, 2%.

Mode of Action-

Interpretations of in vivo studies suggest that ketoconazole impairs the synthesis of ergosterol, which is a vital component of fungal cell membranes. It is postulated, but not proven, that the therapeutic effect of ketoconazole in tinea (pityriasis) versicolor is due to the reduction of Pityrosporum orbiculare (Malassezia furfur) and that the therapeutic effect in dandruff is due to the reduction of Pityrosporum ovale. Support for the therapeutic effect in tinea versicolor comes from a three-arm, parallel, double-blind, placebo controlled study in patients who had moderately severe tinea (pityriasis) versicolor. Successful response rates in the primary efficacy population for each of both three-day and single-day regimens of ketoconazole shampoo, 2% were statistically significantly greater (73% and 69%, respectively) than a placebo regimen (5%). There had been mycological confirmation of fungal disease in all cases at baseline. Mycological clearing rates were 84% and 78%, respectively, for the three-day and one-day regimens of the 2% shampoo and 11% in the placebo regimen. While the differences in the rates of successful response between either of the two active treatments and placebo were statistically significant, the difference between the two active regimens was not.

Microbiology-

Ketoconazole is a broad spectrum synthetic antifungal agent which inhibits the growth of the following common dermatophytes and yeasts by altering the permeability of the cell membrane: dermatophytes: Trichophyton rubrum, T. mentagrophytes, T. tonsurans, Microsporum canis, M. audouini, M. gypseum and Epidermophyton floccosum; yeasts: Candida albicans, C. tropicalis, Pityrosporum ovale (Malassezia ovale) and Pityrosporum orbiculare (M. furfur ). Development of resistance by these microorganisms to ketoconazole has not been reported.


INDICATIONS & USAGE SECTION

INDICATIONS AND USAGE

Ketoconazole Shampoo, 2% is indicated for the treatment of tinea (pityriasis) versicolor caused by or presumed to be caused by Pityrosporum orbiculare (also known as Malassezia furfur or M. orbiculare).

Note: Tinea (pityriasis) versicolor may give rise to hyperpigmented or hypopigmented patches on the trunk which may extend to the neck, arms and upper thighs. Treatment of the infection may not immediately result in normalization of pigment to the affected sites. Normalization of pigment following successful therapy is variable and may take months, depending on individual skin type and incidental sun exposure. Although tinea versicolor is not contagious, it may recur because the organism that causes the disease is part of the normal skin flora.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION

Apply the shampoo to the damp skin of the affected area and a wide margin surrounding this area. Lather, leave in place for 5 minutes, and then rinse off with water.

One application of the shampoo should be sufficient.


CONTRAINDICATIONS SECTION

CONTRAINDICATIONS

Ketoconazole Shampoo, 2% is contraindicated in persons who have known hypersensitivity to the active ingredient or excipients of this formulation.


OVERDOSAGE SECTION

OVERDOSAGE

Ketoconazole Shampoo, 2% is intended for external use only. In the event of accidental ingestion, supportive and symptomatic measures should be employed. Induced emesis and gastric lavage should not be performed to avoid aspiration.


HOW SUPPLIED SECTION

HOW SUPPLIED

Product: 53002-1381

NDC: 53002-1381-1 120 mL in a BOTTLE

STORAGE AND HANDLING SECTION

STORAGE

Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Protect from light.


SPL UNCLASSIFIED SECTION

Manufactured By Padagis

Yeruham, Israel

Distributed By

Padagis

Allegan, MI 49010

www.padagis.com

4L926RCF6

Rev 10-22


© Copyright 2025. All Rights Reserved by MedPath